{
    "hands_on_practices": [
        {
            "introduction": "Raw case counts from surveillance programs provide a vital, real-time signal, but they are rarely a perfect measure of a pathogen's true spread. Diagnostic tests have inherent limitations, described by their sensitivity ($Se$) and specificity ($Sp$), which can lead to both false positives and false negatives. This practice  will guide you through the fundamental epidemiological method for correcting observed incidence data for test imperfections and, just as importantly, for quantifying the uncertainty in your final, more accurate estimate.",
            "id": "4992991",
            "problem": "A national surveillance program for a novel respiratory pathogen conducts polymerase chain reaction testing on a cohort of $n$ individuals during a two-week period and reports an observed cumulative incidence proportion (risk) $\\hat{p}_{\\mathrm{obs}}$ as the fraction of tested individuals with a positive result in that period. The diagnostic test has nonperfect sensitivity and specificity, and their uncertainties are characterized by validation studies independent of the surveillance testing. Let sensitivity be $Se$ with mean $\\mu_{Se}$ and variance $\\sigma_{Se}^{2}$, and specificity be $Sp$ with mean $\\mu_{Sp}$ and variance $\\sigma_{Sp}^{2}$. Assume independence among $\\hat{p}_{\\mathrm{obs}}$, $Se$, and $Sp$, and that the test is informative so that $Se + Sp  1$.\n\nStarting from the core definitions $Se = P(\\text{test} + \\mid \\text{disease})$, $Sp = P(\\text{test} - \\mid \\text{no disease})$, and the law of total probability, derive the bias-corrected estimator $\\hat{p}_{\\mathrm{true}}$ of the true cumulative incidence proportion in terms of $\\hat{p}_{\\mathrm{obs}}$, $Se$, and $Sp$. Then, using a first-order Delta method that treats $\\hat{p}_{\\mathrm{true}}$ as a smooth function $g(\\hat{p}_{\\mathrm{obs}}, Se, Sp)$, derive a closed-form analytic expression for the approximate variance $\\mathrm{Var}(\\hat{p}_{\\mathrm{true}})$ that propagates uncertainty from the sampling variability of $\\hat{p}_{\\mathrm{obs}}$ and from the test performance parameters $Se$ and $Sp$. Model the sampling variability of $\\hat{p}_{\\mathrm{obs}}$ by a binomial variance $\\mathrm{Var}(\\hat{p}_{\\mathrm{obs}}) = \\hat{p}_{\\mathrm{obs}}(1 - \\hat{p}_{\\mathrm{obs}})/n$.\n\nProvide your final answer as a single closed-form analytic expression for $\\mathrm{Var}(\\hat{p}_{\\mathrm{true}})$ in terms of $\\hat{p}_{\\mathrm{obs}}$, $Se$, $Sp$, $n$, $\\sigma_{Se}^{2}$, and $\\sigma_{Sp}^{2}$. Express all proportions as decimals or fractions. No rounding is required.",
            "solution": "The problem statement is scientifically grounded, well-posed, objective, and self-contained, providing all necessary information for a unique solution. The scenario describes a standard and important task in epidemiology: correcting an observed disease frequency measure for the imperfections of a diagnostic test and quantifying the uncertainty in the corrected estimate. The methods specified—the law of total probability and the Delta method for variance propagation—are appropriate and standard for this context. Therefore, the problem is valid, and I will proceed with the derivation.\n\nThe overall task is to first derive the bias-corrected estimator for the true cumulative incidence proportion, $\\hat{p}_{\\mathrm{true}}$, and then to derive the variance of this estimator, $\\mathrm{Var}(\\hat{p}_{\\mathrm{true}})$, using a first-order Delta method.\n\n**Part 1: Derivation of the Bias-Corrected Estimator $\\hat{p}_{\\mathrm{true}}$**\n\nLet $p_{\\mathrm{true}}$ be the true cumulative incidence proportion in the population and $p_{\\mathrm{obs}}$ be the proportion of individuals who test positive. Let $D$ denote the event that an individual has the disease and $T+$ denote the event of a positive test result.\nThe definitions provided are:\n-   True cumulative incidence: $p_{\\mathrm{true}} = P(D)$\n-   Observed cumulative incidence: $p_{\\mathrm{obs}} = P(T+)$\n-   Sensitivity: $Se = P(T+ \\mid D)$\n-   Specificity: $Sp = P(T- \\mid D^c)$, where $D^c$ is the complement of $D$. From this, the probability of a false positive is $P(T+ \\mid D^c) = 1 - Sp$.\n\nUsing the law of total probability, we can express the probability of an observed positive test, $P(T+)$, in terms of the true incidence and the test characteristics:\n$$P(T+) = P(T+ \\mid D) P(D) + P(T+ \\mid D^c) P(D^c)$$\nSubstituting the defined parameters into this equation gives:\n$$p_{\\mathrm{obs}} = Se \\cdot p_{\\mathrm{true}} + (1 - Sp) \\cdot (1 - p_{\\mathrm{true}})$$\nOur objective is to solve this equation for $p_{\\mathrm{true}}$. We expand the right-hand side:\n$$p_{\\mathrm{obs}} = Se \\cdot p_{\\mathrm{true}} + 1 - Sp - p_{\\mathrm{true}} + Sp \\cdot p_{\\mathrm{true}}$$\nGroup the terms containing $p_{\\mathrm{true}}$:\n$$p_{\\mathrm{obs}} = p_{\\mathrm{true}}(Se + Sp - 1) + 1 - Sp$$\nNow, we isolate $p_{\\mathrm{true}}$:\n$$p_{\\mathrm{obs}} - (1 - Sp) = p_{\\mathrm{true}}(Se + Sp - 1)$$\n$$p_{\\mathrm{obs}} + Sp - 1 = p_{\\mathrm{true}}(Se + Sp - 1)$$\nDividing by the term $(Se + Sp - 1)$, which is guaranteed to be non-zero by the given condition $Se + Sp  1$, yields the expression for the true incidence proportion:\n$$p_{\\mathrm{true}} = \\frac{p_{\\mathrm{obs}} + Sp - 1}{Se + Sp - 1}$$\nThe bias-corrected estimator $\\hat{p}_{\\mathrm{true}}$ is obtained by substituting the observed sample proportion $\\hat{p}_{\\mathrm{obs}}$ into this formula. The test characteristics $Se$ and $Sp$ are also treated as variables for the subsequent variance calculation. Thus, we define the function $g$:\n$$\\hat{p}_{\\mathrm{true}} = g(\\hat{p}_{\\mathrm{obs}}, Se, Sp) = \\frac{\\hat{p}_{\\mathrm{obs}} + Sp - 1}{Se + Sp - 1}$$\n\n**Part 2: Derivation of the Variance of $\\hat{p}_{\\mathrm{true}}$**\n\nWe use the first-order multivariate Delta method to approximate the variance of $\\hat{p}_{\\mathrm{true}}$. The problem states that $\\hat{p}_{\\mathrm{obs}}$, $Se$, and $Sp$ are independent random variables. The general formula for the variance of a function $g(X_1, X_2, X_3)$ of three independent random variables is:\n$$\\mathrm{Var}(g) \\approx \\sum_{i=1}^{3} \\left( \\frac{\\partial g}{\\partial X_i} \\right)^2 \\mathrm{Var}(X_i)$$\nIn our case, $X_1 = \\hat{p}_{\\mathrm{obs}}$, $X_2 = Se$, and $X_3 = Sp$. The variance approximation is:\n$$\\mathrm{Var}(\\hat{p}_{\\mathrm{true}}) \\approx \\left( \\frac{\\partial g}{\\partial \\hat{p}_{\\mathrm{obs}}} \\right)^2 \\mathrm{Var}(\\hat{p}_{\\mathrm{obs}}) + \\left( \\frac{\\partial g}{\\partial Se} \\right)^2 \\mathrm{Var}(Se) + \\left( \\frac{\\partial g}{\\partial Sp} \\right)^2 \\mathrm{Var}(Sp)$$\nThe problem provides the following variances:\n-   $\\mathrm{Var}(\\hat{p}_{\\mathrm{obs}}) = \\frac{\\hat{p}_{\\mathrm{obs}}(1 - \\hat{p}_{\\mathrm{obs}})}{n}$\n-   $\\mathrm{Var}(Se) = \\sigma_{Se}^{2}$\n-   $\\mathrm{Var}(Sp) = \\sigma_{Sp}^{2}$\n\nNext, we compute the partial derivatives of $g(\\hat{p}_{\\mathrm{obs}}, Se, Sp)$:\n\n1.  Partial derivative with respect to $\\hat{p}_{\\mathrm{obs}}$:\n    $$\\frac{\\partial g}{\\partial \\hat{p}_{\\mathrm{obs}}} = \\frac{\\partial}{\\partial \\hat{p}_{\\mathrm{obs}}} \\left( \\frac{\\hat{p}_{\\mathrm{obs}} + Sp - 1}{Se + Sp - 1} \\right) = \\frac{1}{Se + Sp - 1}$$\n\n2.  Partial derivative with respect to $Se$:\n    $$\\frac{\\partial g}{\\partial Se} = \\frac{\\partial}{\\partial Se} \\left( (\\hat{p}_{\\mathrm{obs}} + Sp - 1)(Se + Sp - 1)^{-1} \\right)$$\n    Using the power rule and chain rule:\n    $$\\frac{\\partial g}{\\partial Se} = (\\hat{p}_{\\mathrm{obs}} + Sp - 1) \\cdot (-1) \\cdot (Se + Sp - 1)^{-2} \\cdot (1) = - \\frac{\\hat{p}_{\\mathrm{obs}} + Sp - 1}{(Se + Sp - 1)^{2}}$$\n\n3.  Partial derivative with respect to $Sp$:\n    $$\\frac{\\partial g}{\\partial Sp} = \\frac{\\partial}{\\partial Sp} \\left( \\frac{\\hat{p}_{\\mathrm{obs}} + Sp - 1}{Se + Sp - 1} \\right)$$\n    Using the quotient rule, $\\frac{u'v - uv'}{v^2}$, with $u = \\hat{p}_{\\mathrm{obs}} + Sp - 1$ and $v = Se + Sp - 1$:\n    $$\\frac{\\partial u}{\\partial Sp} = 1, \\quad \\frac{\\partial v}{\\partial Sp} = 1$$\n    $$\\frac{\\partial g}{\\partial Sp} = \\frac{(1)(Se + Sp - 1) - (\\hat{p}_{\\mathrm{obs}} + Sp - 1)(1)}{(Se + Sp - 1)^{2}} = \\frac{Se + Sp - 1 - \\hat{p}_{\\mathrm{obs}} - Sp + 1}{(Se + Sp - 1)^{2}} = \\frac{Se - \\hat{p}_{\\mathrm{obs}}}{(Se + Sp - 1)^{2}}$$\n\nNow, we substitute these partial derivatives and the given variances into the Delta method formula:\n$$\\mathrm{Var}(\\hat{p}_{\\mathrm{true}}) \\approx \\left(\\frac{1}{Se + Sp - 1}\\right)^{2} \\left(\\frac{\\hat{p}_{\\mathrm{obs}}(1 - \\hat{p}_{\\mathrm{obs}})}{n}\\right) + \\left(- \\frac{\\hat{p}_{\\mathrm{obs}} + Sp - 1}{(Se + Sp - 1)^{2}}\\right)^{2} \\sigma_{Se}^{2} + \\left(\\frac{Se - \\hat{p}_{\\mathrm{obs}}}{(Se + Sp - 1)^{2}}\\right)^{2} \\sigma_{Sp}^{2}$$\nSimplifying each term gives the final expression for the approximate variance:\n$$\\mathrm{Var}(\\hat{p}_{\\mathrm{true}}) \\approx \\frac{\\hat{p}_{\\mathrm{obs}}(1 - \\hat{p}_{\\mathrm{obs}})}{n(Se + Sp - 1)^{2}} + \\frac{(\\hat{p}_{\\mathrm{obs}} + Sp - 1)^{2}}{(Se + Sp - 1)^{4}} \\sigma_{Se}^{2} + \\frac{(Se - \\hat{p}_{\\mathrm{obs}})^{2}}{(Se + Sp - 1)^{4}} \\sigma_{Sp}^{2}$$\nThis expression gives the variance of the corrected cumulative incidence proportion, accounting for uncertainty from the initial sampling of individuals ($\\mathrm{Var}(\\hat{p}_{\\mathrm{obs}})$) and from the characterization of the diagnostic test's performance ($\\sigma_{Se}^{2}$ and $\\sigma_{Sp}^{2}$).",
            "answer": "$$\n\\boxed{\\frac{\\hat{p}_{\\mathrm{obs}}(1 - \\hat{p}_{\\mathrm{obs}})}{n(Se + Sp - 1)^{2}} + \\frac{(\\hat{p}_{\\mathrm{obs}} + Sp - 1)^{2}}{(Se + Sp - 1)^{4}} \\sigma_{Se}^{2} + \\frac{(Se - \\hat{p}_{\\mathrm{obs}})^{2}}{(Se + Sp - 1)^{4}} \\sigma_{Sp}^{2}}\n$$"
        },
        {
            "introduction": "Estimating the true severity of a new pathogen, often measured by the Infection Fatality Rate (IFR), is a far more complex task than simply dividing deaths by cases. This exercise  demonstrates how epidemiologists act as detectives, synthesizing information from serology surveys, death reports, and knowledge of the disease's timeline to construct an accurate IFR. You will learn to correct for a cascade of real-world issues, including test errors, reporting lags, and antibody waning, to piece together a reliable estimate from imperfect data.",
            "id": "4993002",
            "problem": "A metropolitan area has a population of $N = 5{,}000{,}000$. A severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serosurvey was conducted on calendar date $t_{s} = \\text{July }15$ using a commercial immunoassay. The survey sampled $n = 4{,}000$ individuals, of whom $k = 700$ tested seropositive. The assay’s sensitivity (true positive rate) was $\\text{Se} = 0.92$ and specificity (true negative rate) was $\\text{Sp} = 0.98$. Independent cohort data suggest that, at the time of the survey, a fraction $p_{\\text{wane}} = 0.10$ of previously infected individuals had seroreverted (antibodies had waned below the detection threshold).\n\nThe average delay from infection to seroconversion is $d_{\\text{sc}} = 10$ days, and the average delay from infection to death is $d_{\\text{id}} = 21$ days. Public health reports indicate that cumulative confirmed cases by $t_{c} = \\text{July }5$ were $C(t_{c}) = 180{,}000$. Cumulative reported deaths by $t_{d} = \\text{July }26$ were $D_{\\text{rep}}(t_{d}) = 5{,}200$, and the death reporting system is estimated to have completeness $c_{d} = 0.85$ (that is, $85\\%$ of deaths are captured).\n\nUsing the fundamental definitions that the Case Fatality Rate (CFR) is the proportion of confirmed cases that eventually die and the Infection Fatality Rate (IFR) is the proportion of all infections (including unconfirmed and asymptomatic) that eventually die, and using well-tested principles of diagnostic test misclassification and time-to-event alignment:\n\n- Derive, from first principles and the provided quantities, an analytic expression for the adjusted IFR for infections accumulated up to $\\text{July }5$, aligning deaths with infections via the stated delays, correcting the seroprevalence for imperfect sensitivity and specificity, and accounting for seroreversion at the time of the survey. You may use any algebraic relationships that follow from the above definitions and facts, but do not introduce assumptions or formulas not justified by these definitions and widely accepted epidemiologic reasoning.\n\n- Compute the numerical value of the adjusted IFR as a decimal, rounding to three significant figures. Express the answer as a decimal number (do not use a percentage sign).\n\nAdditionally, in words (no calculation required), briefly explain at least two major sources of bias that can affect serology-based IFR estimates even after applying the above adjustments, and indicate the direction in which each bias might skew the IFR (upward or downward) under typical conditions.",
            "solution": "This problem is scientifically grounded, using established principles of epidemiology such as seroprevalence estimation, diagnostic test correction (Rogan-Gladen estimator), and accounting for reporting delays and incompleteness. A key feature demonstrating its well-posed nature is the deliberate alignment of time points. The serosurvey on July 15 estimates the prevalence of infections that occurred up to July 5 (accounting for the 10-day seroconversion delay), and the cumulative deaths on July 26 estimate fatal outcomes from infections that occurred up to July 5 (accounting for the 21-day infection-to-death delay). This careful construction ensures that the numerator (deaths) and the denominator (infections) correspond to the same cohort of infected individuals, a critical requirement for a valid IFR calculation. The problem is objective, free of ambiguity, and formalizable.\n\nThe objective is to calculate the Infection Fatality Rate (IFR), defined as the ratio of the total number of deaths to the total number of infections for a specific cohort.\n$$ \\text{IFR} = \\frac{\\text{Total True Deaths}}{\\text{Total True Infections}} $$\nWe must estimate the numerator and the denominator for the population infected up to July $5$.\n\n**1. Estimation of the Numerator (Total True Deaths $D_{\\text{true}}$)**\n\nThe total number of true deaths, $D_{\\text{true}}$, corresponding to infections up to July $5$ is estimated from the reported deaths, $D_{\\text{rep}}(t_{d})$, at the appropriately lagged time point $t_d = \\text{July }26$. The reported deaths, $D_{\\text{rep}}(t_{d}) = 5{,}200$, are an undercount due to the reporting completeness being $c_{d} = 0.85$. The true number of deaths is found by correcting for this incompleteness:\n$$ D_{\\text{true}} = \\frac{D_{\\text{rep}}(t_{d})}{c_{d}} $$\n\n**2. Estimation of the Denominator (Total True Infections $I_{\\text{total}}$)**\n\nThe total number of individuals infected by July $5$, denoted $I_{\\text{total}}$, is estimated from the serosurvey conducted on $t_{s} = \\text{July }15$. The estimation proceeds in three steps:\n\nFirst, we calculate the observed seroprevalence, $\\pi_{\\text{obs}}$, from the survey data ($k=700$ positives in a sample of $n=4{,}000$):\n$$ \\pi_{\\text{obs}} = \\frac{k}{n} $$\n\nSecond, we correct $\\pi_{\\text{obs}}$ for the imperfect sensitivity ($\\text{Se}$) and specificity ($\\text{Sp}$) of the assay to find the true seroprevalence, $\\pi_{\\text{true}}$. The observed prevalence is a sum of true positives and false positives, related by the formula:\n$$ \\pi_{\\text{obs}} = \\pi_{\\text{true}} \\cdot \\text{Se} + (1 - \\pi_{\\text{true}}) \\cdot (1 - \\text{Sp}) $$\nRearranging this equation to solve for $\\pi_{\\text{true}}$ (the Rogan-Gladen estimator):\n$$ \\pi_{\\text{true}} = \\frac{\\pi_{\\text{obs}} + \\text{Sp} - 1}{\\text{Se} + \\text{Sp} - 1} $$\n\nThird, this $\\pi_{\\text{true}}$ represents the proportion of the population with detectable antibodies. It does not include individuals who were infected but have seroreverted ($p_{\\text{wane}}$). The true cumulative infection prevalence, $\\pi_{\\text{inf}}$, is therefore:\n$$ \\pi_{\\text{inf}} = \\frac{\\pi_{\\text{true}}}{1 - p_{\\text{wane}}} $$\nThe total number of infections, $I_{\\text{total}}$, is this prevalence multiplied by the total population $N$:\n$$ I_{\\text{total}} = N \\cdot \\pi_{\\text{inf}} = N \\cdot \\frac{1}{1 - p_{\\text{wane}}} \\left( \\frac{\\frac{k}{n} + \\text{Sp} - 1}{\\text{Se} + \\text{Sp} - 1} \\right) $$\n\n**3. Analytic Expression and Numerical Calculation of IFR**\n\nCombining the expressions for the numerator and denominator gives the final analytic expression for the adjusted IFR:\n$$ \\text{IFR} = \\frac{D_{\\text{true}}}{I_{\\text{total}}} = \\frac{\\frac{D_{\\text{rep}}(t_{d})}{c_{d}}}{N \\cdot \\frac{1}{1 - p_{\\text{wane}}} \\left( \\frac{\\frac{k}{n} + \\text{Sp} - 1}{\\text{Se} + \\text{Sp} - 1} \\right)} $$\n\nNow, we substitute the provided numerical values: $D_{\\text{rep}}(t_{d}) = 5{,}200$, $c_{d} = 0.85$, $N = 5{,}000{,}000$, $p_{\\text{wane}} = 0.10$, $k = 700$, $n = 4{,}000$, $\\text{Se} = 0.92$, $\\text{Sp} = 0.98$.\n\nFirst, calculate the numerator:\n$$ D_{\\text{true}} = \\frac{5{,}200}{0.85} \\approx 6117.65 $$\n\nNext, calculate the components of the denominator:\n-   Observed prevalence: $\\pi_{\\text{obs}} = \\frac{700}{4{,}000} = 0.175$\n-   True seroprevalence: $\\pi_{\\text{true}} = \\frac{0.175 + 0.98 - 1}{0.92 + 0.98 - 1} = \\frac{0.155}{0.90} \\approx 0.17222$\n-   True cumulative infection prevalence: $\\pi_{\\text{inf}} = \\frac{0.17222}{1 - 0.10} = \\frac{0.17222}{0.90} \\approx 0.19136$\n-   Total infections: $I_{\\text{total}} = 5{,}000{,}000 \\times 0.19136 \\approx 956{,}800$\n\nFinally, compute the IFR:\n$$ \\text{IFR} = \\frac{6117.65}{956800} \\approx 0.0063941 $$\nRounding to three significant figures, the adjusted IFR is $0.00639$.\n\n### Additional Sources of Bias\n\nEven after the adjustments for test characteristics, reporting delays, reporting completeness, and seroreversion, other systematic errors (biases) can affect the IFR estimate. Two major sources are:\n\n1.  **Selection Bias in Serosurvey Sampling:** The sample of $n=4{,}000$ individuals may not be representative of the total population of $N=5{,}000{,}000$. For example, if the survey preferentially enrolled healthcare workers or individuals with previous symptoms (who are more likely to have been exposed), the observed prevalence $\\pi_{\\text{obs}}$ would be artificially high. This would inflate the estimate of total infections, $I_{\\text{total}}$, and consequently skew the calculated IFR **downward**. Conversely, if the sample was biased towards more cautious individuals who successfully avoided infection, the prevalence would be underestimated, and the IFR would be skewed **upward**.\n\n2.  **Bias from Non-Uniform Population Risk and Dynamics:** The calculation assumes a homogeneous risk of death across all infected individuals. In reality, the IFR is highly dependent on age and comorbidities. If the virus had disproportionately infected a younger, healthier demographic by July $5$, the calculated IFR would be an underestimate of the true population-average IFR that would emerge once the virus spread more widely into older, more vulnerable populations. This would cause a **downward** bias relative to the eventual, overall IFR. Furthermore, using average delays for alignment ($d_{sc}$, $d_{id}$) can introduce bias if the epidemic growth rate is not constant; for a rapidly accelerating epidemic, the number of deaths by July $26$ would represent only a fraction of the eventual deaths from the infection cohort, leading to a **downward** bias in the IFR.",
            "answer": "$$\\boxed{0.00639}$$"
        },
        {
            "introduction": "Effective pandemic response is not just about understanding the virus, but also about making optimal decisions with limited resources and information. Public health policies, such as quarantine, involve trade-offs between societal burden and risk reduction. This hands-on problem  puts you in the role of a decision-maker, using mathematical optimization to determine the ideal quarantine duration that balances these competing costs.",
            "id": "4993034",
            "problem": "A public health authority is designing a quarantine policy for exposed contacts under a test-on-release strategy in a respiratory pandemic. Each exposed contact is quarantined for a duration of $T$ days from the time of exposure and then undergoes a Polymerase Chain Reaction (PCR) test at release. If the test is negative, the person is released; otherwise, the person remains isolated. The authority seeks to choose $T$ to minimize the expected total societal cost per quarantined contact by balancing quarantine burden against the residual risk of releasing infected individuals who test falsely negative while still infectious.\n\nAssume the following fundamental base and modeling assumptions, consistent with commonly used survival and detection models in infectious disease epidemiology:\n\n1. Among quarantined contacts, the probability of being infected is $p$. For an infected individual at time $t$ since exposure, the probability that the PCR test would return positive is given by the cumulative detectability function $S(t) = 1 - \\exp(-\\alpha t)$, where $\\alpha$ is a constant detection rate. Therefore, the false negative probability at time $t$ is $\\exp(-\\alpha t)$.\n\n2. The infectious period duration for an infected individual is exponentially distributed with rate $\\beta$, so the probability that the individual remains infectious at time $t$ since exposure equals the survival function $\\exp(-\\beta t)$.\n\n3. The expected societal cost per quarantined contact consists of two parts:\n   (i) a quarantine burden cost $c_q$ per day applied to every quarantined contact for the full $T$ days, so this component equals $c_q T$;\n   (ii) an expected harm cost from releasing an infected individual who is still infectious due to a false negative test at time $T$. Denote the monetized expected harm per such release as $c_h$. Under the model above, this expected harm contributes $p \\times \\exp(-\\alpha T) \\times \\exp(-\\beta T) \\times c_h$ per quarantined contact.\n\nUnder these assumptions, derive the quarantine duration $T^{\\ast}$ that minimizes the expected total societal cost per contact. Then, using the parameter values $p = 0.10$, $\\alpha = 0.45\\ \\text{day}^{-1}$, $\\beta = 0.30\\ \\text{day}^{-1}$, $c_q = 100$ cost units per day, and $c_h = 60{,}000$ cost units, compute $T^{\\ast}$. Express the final duration in days and round your answer to four significant figures.",
            "solution": "The problem requires finding an optimal quarantine duration by minimizing a societal cost function. This is a classic optimization problem in public health policy, grounded in epidemiological modeling and cost-benefit analysis. The cost function is explicitly defined as the sum of a linear quarantine burden and an exponential risk cost, which is a standard and well-posed formulation. The problem is valid, and the solution proceeds by using calculus to find the minimum of this function.\n\nThe objective is to find the quarantine duration $T$ that minimizes the expected total societal cost per quarantined contact, denoted as $C(T)$. The cost function is the sum of the quarantine burden cost and the expected harm cost from releasing an infectious individual.\n\nThe total cost function $C(T)$ is given by:\n$$C(T) = c_q T + p \\cdot c_h \\cdot \\exp(-\\alpha T) \\cdot \\exp(-\\beta T)$$\nThe two exponential terms can be combined:\n$$C(T) = c_q T + p c_h \\exp(-(\\alpha + \\beta)T)$$\nTo find the value of $T$ that minimizes this cost, we must apply calculus. We will find the first derivative of $C(T)$ with respect to $T$ and set it to zero to find the critical points.\n\nThe first derivative is:\n$$\\frac{dC}{dT} = \\frac{d}{dT} \\left( c_q T + p c_h \\exp(-(\\alpha + \\beta)T) \\right)$$\nUsing the sum rule and the chain rule for differentiation:\n$$\\frac{dC}{dT} = c_q + p c_h \\cdot \\frac{d}{dT} \\left( \\exp(-(\\alpha + \\beta)T) \\right)$$\n$$\\frac{dC}{dT} = c_q + p c_h \\cdot \\exp(-(\\alpha + \\beta)T) \\cdot (-(\\alpha + \\beta))$$\n$$\\frac{dC}{dT} = c_q - p c_h (\\alpha + \\beta) \\exp(-(\\alpha + \\beta)T)$$\n\nTo find the optimal duration $T^{\\ast}$, we set the first derivative to zero:\n$$c_q - p c_h (\\alpha + \\beta) \\exp(-(\\alpha + \\beta)T^{\\ast}) = 0$$\nNow, we solve for $T^{\\ast}$:\n$$p c_h (\\alpha + \\beta) \\exp(-(\\alpha + \\beta)T^{\\ast}) = c_q$$\n$$\\exp(-(\\alpha + \\beta)T^{\\ast}) = \\frac{c_q}{p c_h (\\alpha + \\beta)}$$\nTaking the natural logarithm of both sides:\n$$-(\\alpha + \\beta)T^{\\ast} = \\ln\\left(\\frac{c_q}{p c_h (\\alpha + \\beta)}\\right)$$\nIsolating $T^{\\ast}$ and using the property $\\ln(1/x) = -\\ln(x)$:\n$$T^{\\ast} = -\\frac{1}{\\alpha + \\beta} \\ln\\left(\\frac{c_q}{p c_h (\\alpha + \\beta)}\\right) = \\frac{1}{\\alpha + \\beta} \\ln\\left(\\frac{p c_h (\\alpha + \\beta)}{c_q}\\right)$$\nTo confirm that this critical point corresponds to a minimum, we evaluate the second derivative of $C(T)$. Since all parameters ($p, c_h, \\alpha, \\beta$) are positive, the second derivative $\\frac{d^2C}{dT^2} = p c_h (\\alpha + \\beta)^2 \\exp(-(\\alpha + \\beta)T)$ is always positive. This confirms that the cost function $C(T)$ is convex and our solution $T^{\\ast}$ is a global minimum.\n\nNow, we substitute the provided numerical values into the expression for $T^{\\ast}$:\n$p = 0.10$\n$\\alpha = 0.45\\ \\text{day}^{-1}$\n$\\beta = 0.30\\ \\text{day}^{-1}$\n$c_q = 100$\n$c_h = 60{,}000$\n\nFirst, calculate the sum of the rates:\n$$\\alpha + \\beta = 0.45 + 0.30 = 0.75\\ \\text{day}^{-1}$$\nNext, we compute the argument of the natural logarithm:\n$$\\frac{p c_h (\\alpha + \\beta)}{c_q} = \\frac{0.10 \\times 60{,}000 \\times 0.75}{100}$$\n$$\\frac{p c_h (\\alpha + \\beta)}{c_q} = \\frac{6{,}000 \\times 0.75}{100} = \\frac{4500}{100} = 45$$\nNow, substitute this result into the equation for $T^{\\ast}$:\n$$T^{\\ast} = \\frac{1}{0.75} \\ln(45)$$\nCalculating the numerical value:\n$$\\ln(45) \\approx 3.80666$$\n$$T^{\\ast} = \\frac{1}{0.75} \\times 3.80666 \\approx 5.07555$$\nThe problem requires the answer to be rounded to four significant figures.\n$$T^{\\ast} \\approx 5.076\\ \\text{days}$$",
            "answer": "$$\n\\boxed{5.076}\n$$"
        }
    ]
}